Anavex Life Sciences Corp (AVXL)

[12x]

Are you suggesting both co-primary endpoints failed?

Also that would be a treatment mean difference of -1.34 not -1.85 (if true, this would not be p=0.033 but about p=0.15)

Either Missling was sloppy or wrong. Pick one. He'll probably blame it on the third party again.

The slides and/or PR also do not report the co-primary endpoint (ADCS-ADL) numbers just a +3.5 point responder analysis which was not the endpoint.